Search Results - "Nambiar, Lavanya"

Coprevalence of type 2 diabetes mellitus and tuberculosis in low‐income and middle‐income countries: A systematic review by McMurry, Hannah Stowe, Mendenhall, Emily, Rajendrakumar, Aravind, Nambiar, Lavanya, Satyanarayana, Srinath, Shivashankar, Roopa

“…Summary Increasing coprevalence of diabetes mellitus (DM) and tuberculosis (TB) in low‐income and middle‐income countries (LMICs) indicates a rising threat to…”
Get full text

Assessment of prevalence of elevated blood lead levels and risk factors among children and pregnant women in Bihar, India by Lu, Yi, Chandan, Ambrish Kumar, Mehta, Sumi, Kushwaha, Meenakshi, Kumar, Arun, Ali, Mohammad, Srivastava, Abhinav, Ghosh, Ashok Kumar, Bose-O'Reilly, Stephan, Nambiar, Lavanya, Kass, Daniel

“…While modeled estimates and studies in contaminated areas indicate high lead exposure among children in Bihar, India, local data on lead exposure in the child…”
Get full text

Exploring the Barriers to and Facilitators of Using Evidence-Based Drugs in the Secondary Prevention of Cardiovascular Diseases: Findings From a Multistakeholder, Qualitative Analysis by Miller, Victoria, Nambiar, Lavanya, Saxena, Malvika, Leong, Darryl, Banerjee, Amitava, Werba, José Pablo, Faria Neto, Jose Rocha, Quinto, Katherine Curi, Moniruzzaman, Mohammed, Khandelwal, Shweta

“…Health-system barriers and facilitators associated with cardiovascular medication adherence have seldom been studied, particularly in low- and middle-income…”
Get full text

Health system barriers and facilitators to medication adherence for the secondary prevention of cardiovascular disease: a systematic review by Banerjee, Amitava, Khandelwal, Shweta, Nambiar, Lavanya, Saxena, Malvika, Peck, Victoria, Moniruzzaman, Mohammed, Faria Neto, Jose Rocha, Quinto, Katherine Curi, Smyth, Andrew, Leong, Darryl, Werba, José Pablo

“…Secondary prevention is cost-effective for cardiovascular disease (CVD), but uptake is suboptimal. Understanding barriers and facilitators to adherence to…”
Get full text

Exploring the Barriers to and Facilitators of Using Evidence-Based Drugs in the Secondary Prevention of Cardiovascular Diseases by Miller, Victoria, Nambiar, Lavanya, Saxena, Malvika, Leong, Darryl, Banerjee, Amitava, Werba, José Pablo, Faria Neto, Jose Rocha, Quinto, Katherine Curi, Moniruzzaman, Mohammed, Khandelwal, Shweta

“…Health-system barriers and facilitators associated with cardiovascular medication adherence have seldom been studied, particularly in low- and middle-income…”
Get full text